跳至主要内容
临床试验/CTRI/2020/06/026062
CTRI/2020/06/026062招募中未知

Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Age - 18-75 years
  • 2) Patients with ACLF - HBV reactivation according to APASL guidelines.
  • 3) MELD < 30 WITH AKI,HE
  • 4) MELD < 30 WITH OUT EXTRAHEPATIC FAILURE

排除标准

  • 1) MELD > 30
  • 2) Co existing hepatitis A,E,D
  • 5) Alcohol intake, substance abuse, HIV, IBD, chronic constipation or diarrhoea
  • 6) Allergy to plasma, protamine or heparin,
  • 7) Active hemorrhage or disseminated intravascular coagulation (DIC)
  • 8) Unstable hemodynamics (e.g., blood pressure <90/60 mmHg, heart rate >100 bpm),
  • 9) Cerebral or myocardiac infarction
  • 10) Pregnancy

研究者

相似试验

尚未招募
不适用
Role of Diet and Faecal Microbiota Transplantation following Bowel Cancer Surgeryow Anterior Resection SyndromeLow Anterior ResectionBowel cancerLow Anterior Resection SyndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiet and Nutrition - Other diet and nutrition disordersSurgery - Other surgeryCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12621001193864Edith Cowan University67
尚未招募
2 期
A study to test the efficacy of rectal installation of faeces from healthy donors who have been screened for richness of healthy bacterial composition (enriched donors) in a patient with ulcerative colitis who have not received any treatment
CTRI/2017/08/009536AIIMS
招募中
2 期
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Randomized, placebo-controlled, double-blind studyirritable bowel syndromefecal microbiota transplantationtreatment outcomequality of life
TCTR20230904002Thammasat university45
已完成
不适用
Efficacy of fecal microbiota transplantation for steroid resistant/ dependent acute graft-versus-host disease of gut, a phase II trial.Steroid resistant/dependent acute graft-versus-host disease of gut after allogeneic hametopoietic stem cell transplantation or donor lymphocyte infusion
JPRN-UMIN000020091Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital17
未知
不适用
Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease
JPRN-UMIN000021399Kinki university10
Effects of drug (Tenofovir, FMT, Plasma Exchange... | 临床试验